Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity.
Environmental factors related to multiple sclerosis in Indian population.
Pharmacological treatments for fatigue associated with palliative care.
Finding benefit in stressful uncertain circumstances: relations to social support and stigma among women with unexplained illnesses.
"It gave me something big in my life to wonder and think about which took over the space … and not MS": managing well-being in multiple sclerosis through art-making.
Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica.
Human neural progenitor cells in central nervous system lesions.
Central nervous system involvement in primary Sjogren`s syndrome manifesting as multiple sclerosis.
Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis.
Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes.
Retrograde retinal damage after acute optic tract lesion in MS.
Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptor.
Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity.
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Plant sterols: Friend or foe in CNS disorders?
CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells.
Quantitative sensory and motor measures detect change over time and correlate with walking speed in individuals with multiple sclerosis.
[Multiple sclerosis (2) - Round table: Upper limb and balance.]
Myelinating Cultures: An In Vitro Tool to Identify Demyelinating and Axopathic Autoantibodies.
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis.
Retinoic acid suppresses IL-17 production and pathogenic activity of γδ T cells in CNS autoimmunity.
Neurorehabilitation for Multiple Sclerosis Patients with Emotional Dysfunctions.
Acupuncture and multiple sclerosis: a review of the evidence.
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
Treating prolactinoma can prevent autoimmune diseases.
Pages
« first
‹ previous
…
492
493
494
495
496
497
498
499
500
…
next ›
last »